研報掘金丨開源證券:維持上汽集團“買入”評級,看好公司長期發展
開源證券研報指出,上汽集團(600104.SH)預計25Q1實現歸母淨利潤30-32億元,同比增長10%-18%;經測算歸母淨利潤中值預計爲31億元,同比增長14.4%,主要系Q1公司銷量實現明顯增長疊加降本增效繼續推進。看好公司在上海市政府的高度支持及在營銷、技術、出海、供應鏈等領域經驗豐富的年輕化管理層的帶領下,發揮國企背景及華爲賦能的優勢,堅定走好電動智能化轉型之路。看好公司長期發展,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.